Yoshida R (2021) Hereditary breast and Ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer 28:1167–1180. https://doi.org/10.1007/s12282-020-01148-2

Article  PubMed  Google Scholar 

Kuchenbaecker KB, Hopper JL, Barnes DR et al (2017) Risks of breast, ovarian, and contralateral Breast Cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402. https://doi.org/10.1001/jama.2017.7112

Article  CAS  PubMed  Google Scholar 

Giri VN, Knudsen KE, Kelly WK et al (2020) Implementation of germline testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. J Clin Oncol 38:2798–2811. https://doi.org/10.1200/JCO.20.00046

Article  CAS  PubMed  PubMed Central  Google Scholar 

Page EC, Bancroft EK, Brook MN et al (2019) Interim results from the IMPACT Study: evidence for prostate-specific Antigen Screening in BRCA2 mutation carriers. Eur Urol 76:831–842. https://doi.org/10.1016/j.eururo.2019.08.019

Article  CAS  PubMed  PubMed Central  Google Scholar 

NCCN Guidelines: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic (Version 1.2024)

King M-C, Levy-Lahad E, Lahad A (2014) Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award. JAMA 312:1091–1092. https://doi.org/10.1001/jama.2014.12483

Article  CAS  PubMed  Google Scholar 

Guzauskas GF, Garbett S, Zhou Z et al (2023) Population genomic screening for three Common Hereditary conditions: a cost-effectiveness analysis. Ann Intern Med 176:585–595. https://doi.org/10.7326/M22-0846

Article  PubMed  Google Scholar 

Offit K, Tkachuk KA, Stadler ZK et al (2020) Cascading after Peridiagnostic Cancer Genetic Testing: an alternative to Population-based screening. J Clin Oncol 38:1398–1408. https://doi.org/10.1200/JCO.19.02010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kurian AW, Katz SJ (2020) Emerging opportunity of Cascade Genetic Testing for Population-wide Cancer Prevention and Control. J Clin Oncol 38:1371–1374. https://doi.org/10.1200/JCO.20.00140

Article  PubMed  Google Scholar 

Forbes C, Fayter D, de Kock S, Quek RG (2019) A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated Breast cancer. Cancer Manag Res 11:2321–2337. https://doi.org/10.2147/CMAR.S189627

Article  PubMed  PubMed Central  Google Scholar 

Sessa C, Balmaña J, Bober SL et al (2023) Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline. Ann Oncol 34:33–47. https://doi.org/10.1016/j.annonc.2022.10.004

Article  CAS  PubMed  Google Scholar 

Frey MK, Ahsan MD, Bergeron H et al (2022) Cascade Testing for Hereditary Cancer syndromes: should we move toward direct relative contact? A systematic review and Meta-analysis. J Clin Oncol 40:4129–4143. https://doi.org/10.1200/JCO.22.00303

Article  PubMed  Google Scholar 

Whitaker KD, Obeid E, Daly MB, Hall MJ (2021) Cascade Genetic Testing for Hereditary Cancer Risk: An Underutilized Tool for Cancer Prevention. JCO Precis Oncol 5:1387–1396. https://doi.org/10.1200/PO.21.00163

Article  PubMed  Google Scholar 

Menko FH, Aalfs CM, Henneman L et al (2013) Informing family members of individuals with Lynch syndrome: a guideline for clinical geneticists. Fam Cancer 12:319–324. https://doi.org/10.1007/s10689-013-9636-9

Article  PubMed  Google Scholar 

Di Pietro ML, Zaçe D, Orfino A et al (2021) Intrafamilial communication of hereditary breast and Ovarian cancer genetic information in Italian women: towards a personalised approach. Eur J Hum Genet 29:250–261. https://doi.org/10.1038/s41431-020-00723-7

Article  PubMed  Google Scholar 

Ongaro G, Petrocchi S, Calvello M et al (2022) Psychological determinants of men’s adherence to Cascade Screening for BRCA1/2. Curr Oncol 29:2490–2503. https://doi.org/10.3390/curroncol29040203

Article  PubMed  PubMed Central  Google Scholar 

Cortesi L, Baldassarri B, Ferretti S et al (2020) A regional population-based hereditary Breast cancer screening tool in Italy: first 5-year results. Cancer Med 9:2579–2589. https://doi.org/10.1002/cam4.2824

Article  PubMed  PubMed Central  Google Scholar 

Godino L, Turchetti D, Jackson L et al (2019) Presymptomatic genetic testing for hereditary cancer in young adults: a survey of young adults and parents. Eur J Hum Genet 27:291–299. https://doi.org/10.1038/s41431-018-0262-8

Article  PubMed  Google Scholar 

Cody N, Green A, McDevitt T, Lynch SA (2008) Cascade screening in BRCA1/2 mutation carriers. Ir Med J 101:140–142

CAS  PubMed  Google Scholar 

Jeong GW, Shin W, Lee DO et al (2021) Uptake of family-specific mutation genetic testing among relatives of patients with Ovarian Cancer with BRCA1 or BRCA2 mutation. Cancer Res Treat 53:207–211. https://doi.org/10.4143/crt.2020.364

Article  CAS  PubMed  Google Scholar 

Julian-Reynier C, Sobol H, Sévilla C et al (2000) Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network. Psychooncology 9:504–510. https://doi.org/10.1002/1099-1611(200011/12)9:6<504::aid-pon491>3.0.co;2-r

Article  CAS  PubMed  Google Scholar 

Sanz J, Ramón y Cajal T, Torres A et al (2010) Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain. Fam Cancer 9:297–304. https://doi.org/10.1007/s10689-009-9313-1

Article  PubMed  Google Scholar 

Lieberman S, Lahad A, Tomer A et al (2018) Familial communication and cascade testing among relatives of BRCA population screening participants. Genet Med 20:1446–1454. https://doi.org/10.1038/gim.2018.26

Article  CAS  PubMed  Google Scholar 

Gauna Cristaldo FB, Touzani R, Apostolidis T et al (2019) Uptake of genetic counseling among adult children of BRCA1/2 mutation carriers in France. Psychooncology 28:1894–1900. https://doi.org/10.1002/pon.5169

Article  PubMed  Google Scholar 

Hesse-Biber S, Dwyer AA, Yi S (2020) Parent of origin differences in psychosocial burden and approach to BRCA risk management. Breast J 26:734–738. https://doi.org/10.1111/tbj.13633

Article  PubMed  Google Scholar 

Dwyer AA, Hesse-Biber S, Flynn B, Remick S (2020) Parent of Origin effects on Family Communication of risk in BRCA + women: a qualitative investigation of human factors in Cascade Screening. Cancers (Basel) 12:2316. https://doi.org/10.3390/cancers12082316

Article  CAS  PubMed  Google Scholar 

Finlay E, Stopfer JE, Burlingame E et al (2008) Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genet Test 12:81–91. https://doi.org/10.1089/gte.2007.0037

Article  PubMed  PubMed Central  Google Scholar 

Godino L, Jackson L, Turchetti D et al (2018) Decision making and experiences of young adults undergoing presymptomatic genetic testing for familial cancer: a longitudinal grounded theory study. Eur J Hum Genet 26:44–53. https://doi.org/10.1038/s41431-017-0030-1

Article  PubMed  Google Scholar 

Battistuzzi L, Franiuk M, Kasparian N et al (2019) A qualitative study on decision-making about BRCA1/2 testing in Italian women. Eur J Cancer Care (Engl) 28:e13083. https://doi.org/10.1111/ecc.13083

Article  PubMed  Google Scholar 

Pedrazzani C, Aceti M, Schweighoffer R et al (2022) The communication chain of genetic risk: analyses of Narrative Data Exploring Proband-Provider and Proband-Family Communication in Hereditary breast and Ovarian Cancer. J Pers Med 12:1249. https://doi.org/10.3390/jpm12081249

Article  PubMed  PubMed Central  Google Scholar 

Sarki M, Ming C, Aceti M et al (2022) Relatives from Hereditary breast and Ovarian Cancer and Lynch Syndrome families forgoing genetic testing: findings from the Swiss CASCADE cohort. J Pers Med 12:1740. https://doi.org/10.3390/jpm12101740

Article  PubMed  PubMed Central  Google Scholar 

Sarki M, Ming C, Aissaoui S et al (2022) Intention to inform relatives, Rates of Cascade Testing, and preference for patient-mediated communication in families concerned with Hereditary breast and Ovarian Cancer and Lynch Syndrome: the Swiss CASCADE cohort. Cancers (Basel) 14:1636. https://doi.org/10.3390/cancers14071636

Article  PubMed  Google Scholar 

Menko FH, van der Velden SL, Griffioen DN et al (2023) Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1/BRCA2 variant? A family cancer clinic evaluation. J Genet Couns. https://doi.org/10.1002/jgc4.1767

Article  PubMed  Google Scholar